Starpharma Holdings Limited (ASX: SPL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Starpharma Holdings Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Starpharma Holdings Limited (ASX: SPL)
Latest News
Share Gainers
Why AGL, Retail Food Group, Starpharma, and TPG shares are rising today
Share Gainers
Why Bendigo Bank, Block, Megaport, and Starpharma shares are rising today
52-Week Lows
5 ASX shares trading near 52-week lows that insiders have been buying
Share Fallers
3 ASX All Ords shares tumbling into the weekend
Healthcare Shares
Starphama share price lunges 5% on product relaunch
Healthcare Shares
Here's why the Starpharma (ASX:SPL) share price is having such a stellar end to the week
Healthcare Shares
4 ASX healthcare shares at 52-week lows
Healthcare Shares
Here's why the Starpharma (ASX:SPL) share price is tumbling 8% today
Healthcare Shares
Starpharma (ASX:SPL) share price lifts on Omicron study results
Share Market News
Not enough: Starpharma (ASX:SPH) share price plunges despite 200% revenue growth
Healthcare Shares
What is happening to the Starpharma (ASX:SPL) share price today?
Healthcare Shares
Starpharma (ASX:SPL) share price shoots 6% higher on Roche agreement
Frequently Asked Questions
-
No, Starpharma does not pay dividends at this time.
-
Starpharma listed on the ASX on 28 September 2000.
SPL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Starpharma Holdings Limited
Starpharma Holdings Ltd (ASX: SPL) is an Australian biotechnology company involved in the development of dendrimer products for pharmaceutical, life science, and other applications.
Dendrimers are synthetically manufactured, nanoscale molecules, particularly useful to the pharmaceutical industry for their unique properties as carriers of other molecular structures.
Starpharma describes itself as a world leader in the field. The company is developing programs for drug delivery applications, the treatment of respiratory viruses, and its VivaGel product.
VivaGel can be used for the management and prevention of bacterial vaginosis and as a coating for condoms. The company's VIRALEZE product is an antiviral nasal spray approved for use in many countries, including Europe and the UK.